Innate inflammation in type 1 diabetes

Translational Research

Volumn 167, Issue 1, 2016, Pages 214-227

  Cabrera, Susanne M ^a,b   Henschel, Angela M ^a,b   Hessner, Martin J ^a,b  

^a Children's Hospital of Wisconsin   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CANAKINUMAB; CASPASE 8; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

BIOBREEDING RAT; DISEASE PREDISPOSITION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; PHYSIOLOGY; RAT;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INFLAMMATION; RATS;

EID: 84952638473     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.04.011     Document Type: Review

References (131)

1. V. Harjutsalo, L. Sjoberg, and J. Tuomilehto Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study Lancet 371 2008 1777 1782
2. S. Zheng, and C.E. Mathews Metabolic abnormalities in the pathogenesis of type 1 diabetes Curr Diab Rep 14 2014 519
3. A. Pugliese The multiple origins of type 1 diabetes Diabet Med 30 2013 135 146
4. D. Dabelea The accelerating epidemic of childhood diabetes Lancet 373 2009 1999 2000
5. A.K. Steck, and M.J. Rewers Genetics of type 1 diabetes Clin Chem 57 2011 176 185
6. J.A. Noble, A.M. Valdes, M.D. Varney, and et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium Diabetes 59 2010 2972 2979
7. S.C. Gough, and M.J. Simmonds The HLA region and autoimmune disease: associations and mechanisms of action Curr Genomics 8 2007 453 465
8. A.K. Mangalam, V. Taneja, and C.S. David HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile J Immunol 190 2013 513 518
9. P. Concannon, S.S. Rich, and G.T. Nepom Genetics of type 1A diabetes N Engl J Med 360 2009 16 1646 1654
10. M.A. Atkinson, and G.S. Eisenbarth Type 1 diabetes: new perspectives on disease pathogenesis and treatment Lancet 358 2001 221 229
11. G.S. Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease N Engl J Med 314 1986 1360 1368
12. P.J. Bingley Clinical applications of diabetes antibody testing J Clin Endocrinol Metab 95 2010 25 33
13. A.G. Ziegler, M. Rewers, O. Simell, and et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children JAMA 309 2013 2473 2479
14. M. Knip, S. Korhonen, P. Kulmala, and et al. Prediction of type 1 diabetes in the general population Diabetes Care 33 2010 1206 1212
15. D. Zipris Innate immunity in type 1 diabetes Diabetes Metab Res Rev 27 2011 824 829
16. J.A. Todd Etiology of type 1 diabetes Immunity 32 2010 457 467
17. X. Wang, S. Jia, R. Geoffrey, R. Alemzadeh, S. Ghosh, and M.J. Hessner Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics J Immunol 180 2008 1929 1937
18. B. Keymeulen, E. Vandemeulebroucke, A.G. Ziegler, and et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2005 2598 2608
19. M.D. Pescovitz, C.J. Greenbaum, H. Krause-Steinrauf, and et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function N Engl J Med 361 2009 2143 2152
20. C.R. Stiller, J. Dupre, M. Gent, and et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset Science 223 1984 1362 1367
21. V. Ablamunits, O. Henegariu, J.B. Hansen, and et al. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation Diabetes 61 2012 145 154
22. P.P. Pagni, D. Bresson, T. Rodriguez-Calvo, and et al. Combination therapy with an anti-IL-1beta antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model Diabetes 63 2014 2015 2025
23. K.M. Gillespie, S.C. Bain, A.H. Barnett, and et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes Lancet 364 2004 1699 1700
24. A.K. Steck, T.K. Armstrong, S.R. Babu, and G.S. Eisenbarth Type 1 diabetes genetics C. Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years Diabetes 60 2011 1045 1049
25. R. Medzhitov Recognition of microorganisms and activation of the immune response Nature 449 2007 819 826
26. M.A. Atkinson, and A. Chervonsky Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease Diabetologia 55 2012 2868 2877
27. J.F. Bach, and L. Chatenoud The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes Cold Spring Harb Perspect Med 2 2012 a007799
28. A.G. Abela, and S. Fava Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level Acta Diabetol 50 2013 859 865
29. M.G. von Herrath, R.S. Fujinami, and J.L. Whitton Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1 2003 151 157
30. O. Vaarala, M.A. Atkinson, and J. Neu The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity Diabetes 57 2008 2555 2562
31. E. Bosi, L. Molteni, M.G. Radaelli, and et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes Diabetologia 49 2006 2824 2827
32. R. Carratu, M. Secondulfo, L. de Magistris, and et al. Altered intestinal permeability to mannitol in diabetes mellitus type I J Pediatr Gastroenterol Nutr 28 1999 264 269
33. M. Kuitunen, T. Saukkonen, J. Ilonen, H.K. Akerblom, and E. Savilahti Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1∗02 allele Autoimmunity 35 2002 365 368
34. A. Sapone, L. de Magistris, M. Pietzak, and et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives Diabetes 55 2006 1443 1449
35. M. Secondulfo, D. Iafusco, R. Carratu, and et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients Dig Liver Dis 36 2004 35 45
36. A.D. Kostic, D. Gevers, H. Siljander, and et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes Cell Host Microbe 17 2015 260 273
37. J.P. Mordes, D.V. Serreze, D.L. Greiner, and A.A. Rossini Animal models of autoimmune diabetes 2004 LIppincott, Williams, and Wilkins Philadelphia
38. H.J. Jacob, A. Pettersson, D. Wilson, Y. Mao, A. Lernmark, and E.S. Lander Genetic dissection of autoimmune type I diabetes in the BB rat Nat Genet 2 1992 56 60
39. A.J. MacMurray, D.H. Moralejo, A.E. Kwitek, and et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene Genome Res 12 2002 1029 1039
40. L. Daheron, T. Zenz, L.D. Siracusa, C. Brenner, and B. Calabretta Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity Nucleic Acids Res 29 2001 1308 1316
41. M. Pandarpurkar, L. Wilson-Fritch, S. Corvera, and et al. Ian4 is required for mitochondrial integrity and T cell survival Proc Natl Acad Sci U S A 100 2003 10382 10387
42. R.D. Schulteis, H. Chu, X. Dai, and et al. Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5 Blood 112 2008 4905 4914
43. D. Lundsgaard, T.L. Holm, L. Hornum, and H. Markholst In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3 Diabetes 54 2005 1040 1047
44. P. Poussier, T. Ning, T. Murphy, D. Dabrowski, and S. Ramanathan Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats J Immunol 174 2005 4081 4089
45. R.S. Tirabassi, D.L. Guberski, E.P. Blankenhorn, and et al. Infection with viruses from several families triggers autoimmune diabetes in LEW∗1WR1 rats: prevention of diabetes by maternal immunization Diabetes 59 2010 110 118
46. J.P. Mordes, R. Bortell, J. Doukas, and et al. The BB/Wor rat and the balance hypothesis of autoimmunity Diabetes Metab Rev 12 1996 103 109
47. D. Zipris, J.L. Hillebrands, R.M. Welsh, and et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations J Immunol 170 2003 3592 3602
48. Y.G. Chen, J.P. Mordes, E.P. Blankenhorn, and et al. Temporal induction of immunoregulatory processes coincides with age-dependent resistance to viral-induced type 1 diabetes Genes Immun 14 2013 387 400
49. K.E. Ellerman, C.A. Richards, D.L. Guberski, W.R. Shek, and A.A. Like Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat Diabetes 45 1996 557 562
50. J.P. Mordes, R. Bortell, E.P. Blankenhorn, A.A. Rossini, and D.L. Greiner Rat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR J 45 2004 278 291
51. D.L. Guberski, V.A. Thomas, W.R. Shek, and et al. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats Science 254 1991 1010 1013
52. E.P. Blankenhorn, L. Cort, D.L. Greiner, D.L. Guberski, and J.P. Mordes Virus-induced autoimmune diabetes in the LEW.1WR1 rat requires Iddm14 and a genetic locus proximal to the major histocompatibility complex Diabetes 58 2009 2930 2938
53. H.S. Kahn, J.M. Lawrence, T.M. Morgan, and et al. Association of type 1 diabetes with month of birth among US youth: the SEARCH for Diabetes in Youth Study Diabetes Care 32 2009 2010 2015
54. E.V. Moltchanova, N. Schreier, N. Lammi, and M. Karvonen Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide Diabet Med 26 2009 673 678
55. L. Andreoletti, D. Hober, C. Hober-Vandenberghe, and et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus J Med Virol 52 1997 121 127
56. M.E. Craig, N.J. Howard, M. Silink, and W.D. Rawlinson Reduced frequency of HLA DRB1∗03-DQB1∗02 in children with type 1 diabetes associated with enterovirus RNA J Infect Dis 187 2003 1562 1570
57. R.F. Helfand, H.E. Gary Jr., C.Y. Freeman, L.J. Anderson, and M.A. Pallansch Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group J Infect Dis 172 1995 1206 1211
58. M. Lonnrot, K. Korpela, M. Knip, and et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study Diabetes 49 2000 1314 1318
59. C. Nairn, D.N. Galbraith, K.W. Taylor, and G.B. Clements Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus Diabet Med 16 1999 509 513
60. S.J. Richardson, A. Willcox, A.J. Bone, A.K. Foulis, and N.G. Morgan The prevalence of enteroviral capsid protein VP1 immunostaining in pancreatic islets in human type 1 diabetes Diabetologia 52 2009 1143 1151
61. L. Sarmiento, E. Cabrera-Rode, L. Lekuleni, and et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes Autoimmunity 40 2007 540 545
62. W.C. Yeung, W.D. Rawlinson, and M.E. Craig Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies BMJ 342 2011 d35
63. O.H. Laitinen, H. Honkanen, O. Pakkanen, and et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes Diabetes 63 2014 446 455
64. S.J. Richardson, P. Leete, A.J. Bone, A.K. Foulis, and N.G. Morgan Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1 Diabetologia 56 2013 185 193
65. J.C. Barrett, D.G. Clayton, P. Concannon, and et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes Nat Genet 41 2009 703 707
66. H.W. Virgin, and J.A. Todd Metagenomics and personalized medicine Cell 147 2011 44 56
67. R.C. Ferreira, H. Guo, R.M. Coulson, and et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes Diabetes 63 2014 2538 2550
68. H. Kallionpaa, L.L. Elo, E. Laajala, and et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility Diabetes 63 2014 2402 2414
69. S. Jia, M. Kaldunski, P. Jailwala, and et al. Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in type 1 diabetes Physiol Genomics 43 2011 697 709
70. M. Kaldunski, S. Jia, R. Geoffrey, and et al. Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat Diabetes 59 2010 2375 2385
71. H. Levy, X. Wang, M. Kaldunski, and et al. Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes Genes Immun 13 2012 593 604
72. S. Bieg, W. Simonson, K. Ellefsen, and A. Lernmark Rel B is an early marker of autoimmune islet inflammation in the biobreeding (BB) rat Pancreas 20 2000 47 54
73. M.J. Hessner, X. Wang, L. Meyer, and et al. Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat J Immunol 173 2004 6993 7002
74. R. Geoffrey, S. Jia, A.E. Kwitek, and et al. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat J Immunol 177 2006 7275 7286
75. J. Sarmiento, R.H. Wallis, T. Ning, and et al. A functional polymorphism of PTPN22 is associated with type 1 diabetes in the BioBreeding rat J Immunol 194 2015 615 629
76. R. Valladares, D. Sankar, N. Li, and et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats PLoS One 5 2010 e10507
77. N. Hara, A.K. Alkanani, D. Ir, and et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy J Immunol 189 2012 3805 3814
78. F. Allantaz, D. Chaussabel, D. Stichweh, and et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade J Exp Med 204 2007 2131 2144
79. P. Khaenam, D. Rinchai, M.C. Altman, and et al. A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma J Transl Med 12 2014 65
80. Q. Zhang, T.L. Fillmore, A.A. Schepmoes, and et al. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes J Exp Med 210 2013 191 203
81. T.A. Aly, A. Ide, K. Humphrey, and et al. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes J Autoimmun 25 suppl 2005 40 45
82. Y.G. Chen, S.M. Cabrera, S. Jia, and et al. Molecular signatures differentiate immune states in type 1 diabetic families Diabetes 63 2014 3960 3973
83. M. Miyara, Y. Yoshioka, A. Kitoh, and et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor Immunity 30 2009 899 911
84. T. Mandrup-Poulsen, K. Bendtzen, J. Nerup, C.A. Dinarello, M. Svenson, and J.H. Nielsen Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans Diabetologia 29 1986 63 67
85. S. Sandler, A. Andersson, and C. Hellerstrom Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets Endocrinology 121 1987 1424 1431
86. G.A. Spinas, B.S. Hansen, S. Linde, and et al. Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans Diabetologia 30 1987 474 480
87. K. Maedler, P. Sergeev, F. Ris, and et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets J Clin Invest 110 2002 851 860
88. K. Yamada, N. Takane-Gyotoku, X. Yuan, F. Ichikawa, C. Inada, and K. Nonaka Mouse islet cell lysis mediated by interleukin-1-induced Fas Diabetologia 39 1996 1306 1312
89. M.D. Dayer-Metroz, C.B. Wollheim, P. Seckinger, and J.M. Dayer A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets J Autoimmun 2 1989 163 171
90. U. Zumsteg, J.I. Reimers, F. Pociot, and et al. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats Diabetologia 36 1993 759 766
91. C.A. Dinarello, A. Simon, and J.W. van der Meer Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nat Rev Drug Discov 11 2012 633 652
92. Y. Dogan, S. Akarsu, B. Ustundag, E. Yilmaz, and M.K. Gurgoze Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children Mediators Inflamm 2006 2006 59206
93. M.J. Hussain, J. Maher, T. Warnock, A. Vats, M. Peakman, and D. Vergani Cytokine overproduction in healthy first degree relatives of patients with IDDM Diabetologia 41 1998 343 349
94. E.M. Bradshaw, K. Raddassi, W. Elyaman, and et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells J Immunol 183 2009 4432 4439
95. E.C. Kaizer, C.L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P.C. White Gene expression in peripheral blood mononuclear cells from children with diabetes J Clin Endocrinol Metab 92 2007 3705 3711
96. A.J. Meyers, R.R. Shah, P.A. Gottlieb, and D. Zipris Altered Toll-like receptor signaling pathways in human type 1 diabetes J Mol Med 88 2010 1221 1231
97. R.C. Padmos, N.C. Schloot, H. Beyan, and et al. Distinct monocyte gene-expression profiles in autoimmune diabetes Diabetes 57 2008 2768 2773
98. J. Kayserova, J. Vcelakova, K. Stechova, and et al. Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients Clin Immunol 153 2014 49 55
99. L.G. Petrich de Marquesini, J. Fu, K.J. Connor, and et al. IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes Diabetologia 53 2010 1451 1460
100. L. Cordain, S.B. Eaton, A. Sebastian, and et al. Origins and evolution of the Western diet: health implications for the 21st century Am J Clin Nutr 81 2005 341 354
101. R.J. de Souza, J.F. Swain, L.J. Appel, and F.M. Sacks Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations Am J Clin Nutr 88 2008 1 11
102. P.D. Cani, R. Bibiloni, C. Knauf, and et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
103. M.A. Hildebrandt, C. Hoffmann, S.A. Sherrill-Mix, and et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity Gastroenterology 137 2009 1716-24.e1-2
104. P.J. Turnbaugh, F. Backhed, L. Fulton, and J.I. Gordon Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome Cell Host Microbe 3 2008 213 223
105. P.J. Turnbaugh, V.K. Ridaura, J.J. Faith, F.E. Rey, R. Knight, and J.I. Gordon The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice Sci Transl Med 1 2009 6ra14
106. J. Walter, and R. Ley The human gut microbiome: ecology and recent evolutionary changes Annu Rev Microbiol 65 2011 411 429
107. J. Neu, C.M. Reverte, A.D. Mackey, and et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes J Pediatr Gastroenterol Nutr 40 2005 589 595
108. C. Patrick, G.S. Wang, D.E. Lefebvre, and et al. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide Diabetes 62 2013 2036 2047
109. J.T. Visser, N.A. Bos, L.F. Harthoorn, and et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats Diabetes Metab Res Rev 28 2012 505 513
110. J.T. Visser, K. Lammers, A. Hoogendijk, and et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat Diabetologia 53 2010 2621 2628
111. T. Watts, I. Berti, A. Sapone, and et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats Proc Natl Acad Sci U S A 102 2005 2916 2921
112. Z. Chen, J. Barbi, S. Bu, and et al. The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3 Immunity 39 2013 272 285
113. J. van Loosdregt, V. Fleskens, J. Fu, and et al. Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity Immunity 39 2013 259 271
114. T.C. Theoharides, L. Wang, X. Pang, and et al. Cloning and cellular localization of the rat mast cell 78-kDa protein phosphorylated in response to the mast cell "stabilizer" cromolyn J Pharmacol Exp Ther 294 2000 810 821
115. A.M. Malfait, A.S. Malik, L. Marinova-Mutafchieva, D.M. Butler, R.N. Maini, and M. Feldmann The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action J Immunol 162 1999 6278 6283
116. M. Nishii, T. Inomata, H. Niwano, and et al. Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis Circulation 114 2006 936 944
117. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
118. C. Yang, A. Jurczyk, P. Diiorio, and et al. Salicylate prevents virus-induced type 1 diabetes in the BBDR rat PLoS One 8 2013 e78050
119. N. Hara, A.K. Alkanani, C.A. Dinarello, and D. Zipris Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes J Mol Med (Berl) 92 2014 93 102
120. N. Hara, A.K. Alkanani, C.A. Dinarello, and D. Zipris Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade Innate Immun 20 2013 574 584
121. L. Mastrandrea, J. Yu, T. Behrens, and et al. Etanercept treatment in children with new-onset type 1 diabetes pilot randomized, placebo-controlled, double-blind study Diabetes Care 32 2009 1244 1249
122. P.A. Gottlieb, A.K. Alkanani, A.W. Michels, and et al. alpha1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes J Clin Endocrinol Metab 99 2014 E1418 E1426
123. Y. Wang, Y. Xiao, L. Zhong, and et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes Diabetes 63 2014 4239 4248
124. S. Janciauskiene, S. Larsson, P. Larsson, R. Virtala, L. Jansson, and T. Stevens Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin Biochem Biophys Res Commun 321 2004 592 600
125. G.B. Pott, E.D. Chan, C.A. Dinarello, and L. Shapiro Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood J Leukoc Biol 85 2009 886 895
126. K. Badenhoop, H. Kahles, and M. Penna-Martinez Vitamin D, immune tolerance, and prevention of type 1 diabetes Curr Diab Rep 12 2012 635 642
127. G.B. Ferreira, C.A. Gysemans, J. Demengeot, and et al. 1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice J Immunol 192 2014 4210 4220
128. A. Ataie-Jafari, S.C. Loke, A.B. Rahmat, and et al. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes Clin Nutr 32 2013 911 917
129. M.A. Gabbay, M.N. Sato, C. Finazzo, A.J. Duarte, and S.A. Dib Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta-cell function in new-onset type 1 diabetes mellitus Arch Pediatr Adolesc Med 166 2012 601 607
130. A. Moran, B. Bundy, D.J. Becker, and et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials Lancet 381 2013 1905 1915
131. Hessner MJ, editor. Serum signature analysis of participants of the Anti-Interleukin-1 in Diabetes Action (AIDA) Trial. Abstracts of American Diabetes Association's 73th annual meeting; 2013; Chicago, IL.